FAQ

Repaglinide:PrThr:Pt:Ser/Plas:Ord

Known as: Repaglinide SerPl Ql, Repaglinid:MevcE?ik:Zml?:Ser/Plaz:Srl, Repaglinida:ACnc:Pt:Sor/Plas:Ord 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2006-2018
0120062018

Related topics

Related topics

3 relations
PlasSerumrepaglinide

Related mentions per year

Related mentions per year

1936-2018
19401960198020002020
Repaglinide:PrThr:Pt:Ser/Plas:Ord
Serum
repaglinide
Plas

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Risk of Hypoglycemia After Concomitant Use of Antidiabetic, Antihypertensive, and Antihyperlipidemic Medications: A Database Study.
Hypoglycemia is the most important complication of antidiabetic medications. Most patients with diabetes mellitus take multiple… (More)
Is this relevant?
2016
2016
Efficacy and safety of repaglinide added to sitagliptin in Japanese patients with type 2 diabetes: A randomized 24-week open-label clinical trial.
Although sitagliptin and repaglinide monotherapies improve postprandial hyperglycemia, the long-term effects and safety of their… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2013
2013
Influence of Hydroxypropyl-β-cyclodextrin on Repaglinide Release from Sustained Release Bioadhesive Buccal Tablets
  • PAVAN KUMAR P AND MADHUSUDAN RAO
  • 2013
Objective: The purpose of this investigation was to study the influence of cyclodextrin complexation on development of sustained… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?
Review
2012
Review
2012
Repaglinide
Repaglinide, a carbamoylmethyl benzoic acid derivative, is the first of a new class of oral antidiabetic agents designed to… (More)
  • figure 1
  • figure 2
  • figure 3
  • table I
  • figure 4
Is this relevant?
2006
2006
Preprandial repaglinide decreases exogenous insulin requirements and HbA1c levels in type 2 diabetic patients taking intensive insulin treatment
In this study, we investigated the effects of combining preprandial repaglinide to the insulin therapy for reducing the exogenous… (More)
  • table 1
  • table 2
  • figure 1
Is this relevant?